Mandatory requirements for pediatric drug development in the EU and the US for novel drugs—A comparative study
Mandatory pediatric legislation has been implemented in the European Union (EU) and the United States (US) to increase research and the availability of drugs for the pediatric population. Differences in the legislative framework can cause different pediatric requirements for similar indications gran...
Main Authors: | Helle Christiansen, Marie L. De Bruin, Christine E. Hallgreen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1009432/full |
Similar Items
-
Pediatric Electrophysiology Device Needs: A Survey from the Pediatric and Congenital Electrophysiology Society Taskforce on Pediatric‐Specific Devices
by: Anne M. Dubin, et al.
Published: (2022-11-01) -
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
by: Sally W. Schwarz, et al.
Published: (2019-05-01) -
Opportunities for Regulatory Changes to Promote Pediatric Device Innovation in the United States: Joint Recommendations From Pediatric Innovator Roundtables
by: Terence Sanger, et al.
Published: (2021-01-01) -
Drugs and Devices
by: Gail A. Van Norman, MD
Published: (2016-08-01) -
Top Selling (2026) Small Molecule Orphan Drugs: A Journey into Their Chemistry
by: Davide Benedetto Tiz, et al.
Published: (2023-01-01)